You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

Go to Close Top

Please see below the educational materials available to Healthcare Professionals in Ireland:

Information for Patients (Patient Card) (January 2022)

Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Volibris is a registered trademark of Gilead, used under licence by the GlaxoSmithKline Group of Companies.